HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
A
Agilent Technologies Inc
Healthcare Diagnostics & Research · California, USA · Reports in usd
Market Cap: $32.59B
Market Cap
$32.59B
Enterprise Val
$34.19B
P/E Ratio
25.26
P/B Ratio
4.72
Trailing PEG (1Y)
-7.07
As Of
May 21, 2026

Overview & Key Metrics

Reporting period: Jan 31, 2026 · Q1 2026
Book Value$6.91B
Gross Margin52.61%
Profit Margin52.61%
Return on Equity19.73%
Return on Assets10.34%
Current Ratio2.07
Debt/Equity0.49
LT Debt/Equity0.44
Revenue Per Share6.34

Income Statement

Jan 31, 2026
Revenue$1.80B
Cost of Revenue$852.0M
Gross Profit$946.0M
R&D$117.0M
SG&A$476.0M
Operating Expenses$593.0M
Operating Income$353.0M
Interest Expense$25.0M
Tax Expense$59.0M
Net Income$305.0M
EPS (Basic)$1.08
EPS (Diluted)$1.07
EBIT$389.0M
EBITDA$456.0M
Consolidated Income$305.0M
Non-Controlling Interests$0.00

Balance Sheet

Jan 31, 2026
Cash & Equivalents$1.76B
Accounts Receivable$1.52B
Inventory$1.06B
Current Assets$4.62B
LT Investments$135.0M
Property, Plant & Equipment$2.08B
Intangibles$4.91B
Non-Current Assets$8.20B
Total Assets$12.81B
Accounts Payable$602.0M
Current Debt$304.0M
Current Liabilities$2.23B
LT Debt$3.05B
Non-Current Liabilities$3.67B
Total Liabilities$5.91B
Total Debt$3.35B
Retained Earnings$1.48B
Shareholder Equity$6.91B
Shares Outstanding283,498,871

Cash Flow Statement

Jan 31, 2026
Operating Cash Flow$268.0M
Investing Cash Flow-$93.0M
Financing Cash Flow-$222.0M
CapEx-$93.0M
Free Cash Flow$175.0M
Depreciation & Amort.$67.0M
Stock-Based Comp$41.0M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid-$2.0M
Equity Issued/Repaid-$121.0M
Dividends Paid-$72.0M
Net Change in Cash-$31.0M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h